not tagged
agendia
[]
#agendia presents data at #asco22 pointing to new signature imprint #immunotherapy prediction and expansion of proprietary #genomic tests utility to identify patients who will benefit most from specific treatments 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.